The risk of adverse pregnancy outcome among pregnancies with extremely low maternal PAPP-A
Authors:
- 18 November 2016
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 36 (12) , 1115-1120
Abstract
The aim of the study was to analyze the risk of adverse pregnancy outcome in three subgroups with extremely low maternal pregnancy-associated plasma protein-A (PAPP-A), that is, p < 0.001), but no difference was detected in the rate of structural anomalies among the three groups. Rates of preterm delivery (p < 0.001) and birth weight < 2 standard deviation below the mean (p < 0.001) increased with decreasing PAPP-A levels. The rates of preeclampsia, stillbirth, and cesarean delivery were not significantly different across the three subgroups. The risks of aneuploidy, spontaneous abortion, preterm delivery, and small for gestational age newborn increased with decreasing PAPP-A. © 2016 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Adverse pregnancy outcome in patients with low pregnancy‐associated plasma protein‐A: The Indian ExperienceJournal of Obstetrics and Gynaecology Research, 2015
- First‐trimester screening biochemical markers (free beta‐subunit human chorionic gonadotropin, pregnancy‐associated plasma protein‐A) and risk of early fetal lossJournal of Obstetrics and Gynaecology Research, 2014
- Histomorphometric characteristics of first trimester chorionic villi in pregnancies with low serum pregnancy-associated plasma protein-A levels: relationship with placental three-dimensional power doppler ultrasonographic vascularizationThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- First trimester pregnancy associated plasma protein-A as a marker for poor pregnancy outcome in patients with early-onset fetal growth restrictionPrenatal Diagnosis, 2009
- Pregnancy outcome in the setting of extremely low first trimester PAPP‐A levelsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2009
- Use of the combined first‐trimester screen result and low PAPP‐A to predict risk of adverse fetal outcomesPrenatal Diagnosis, 2008
- First‐trimester ADAM12 and PAPP‐A as markers for intrauterine fetal growth restriction through their roles in the insulin‐like growth factor systemPrenatal Diagnosis, 2007
- Pregnancy-associated plasma protein-A (PAPP-A): A local regulator of IGF bioavailability through cleavage of IGFBPsGrowth Hormone & IGF Research, 2007
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal developmentDevelopment, 2004